What Happens After a Blood Cancer Diagnosis? Tests, Bone Marrow Evaluation and Next Steps

A blood cancer diagnosis can bring many questions: What type of cancer is it? Will I need more tests? When will treatment start?

After the initial diagnosis, your doctor may recommend further investigations before deciding on the next steps. These tests can help identify the exact type and characteristics of the blood cancer and provide the information needed to plan your care.

Depending on your situation, you may have blood tests, a bone marrow aspiration or biopsy, specialised laboratory tests and sometimes imaging. You may need only some of these investigations.

If you are also considering complementary or integrative care, discuss how it can fit alongside your existing cancer-care plan. At Cancer Healer Center (CHC), Cancer Healer Therapy (CAM) is an individualised, immune-focused supportive approach used alongside the patient’s existing cancer treatment. It does not replace prescribed cancer treatment.

Why are more tests needed after a blood cancer diagnosis?

Blood cancer is not one disease. It includes leukaemias, lymphomas, multiple myeloma and other cancers affecting blood-forming or lymphatic tissues.

Finding abnormal cells may therefore be only one part of the diagnostic process. Further investigations may help your medical team understand:

• The exact type or subtype of blood cancer
• Which blood or bone marrow cells are affected
• Characteristics of the abnormal cells
• Relevant chromosome or molecular changes
• Whether other parts of the body are involved
• How organs such as your kidneys and liver are functioning
• Which treatment options may be appropriate

Importantly, needing further tests does not automatically mean that your cancer has become worse. Often, testing is necessary to classify the disease correctly and plan appropriate treatment.

The National Cancer Institute (NCI) notes that laboratory tests, imaging and biopsies can provide different pieces of information about a cancer and help guide treatment planning.

What blood tests might you need?

Complete blood count (CBC)

A complete blood count, or CBC, measures red blood cells, white blood cells, platelets and haemoglobin.

Changes in these measurements can provide useful information. A CBC can help diagnose some cancers, particularly leukaemias, and can also be used to monitor health during and after treatment. However, a CBC alone cannot diagnose every blood cancer.

Peripheral blood examination

A blood sample may also be examined under a microscope. Specialists look at the number, appearance and maturity of different blood cells.

These findings are considered together with your blood counts and other test results.

Blood chemistry and disease-specific tests

Blood chemistry tests provide information about substances in your blood and can help doctors assess how organs such as your kidneys and liver are functioning.

Additional tests depend on the suspected cancer. For example, multiple myeloma assessment can include blood and urine tests for M protein, immunoglobulins and free light chains.

Why might you need a bone marrow test?

Bone marrow is the soft tissue inside certain bones where blood cells are produced.

Some blood cancers begin in or affect the bone marrow. Examining a marrow sample can therefore provide information that cannot always be obtained from an ordinary blood sample.

Bone marrow aspiration or biopsy may help doctors:

• Confirm or refine a diagnosis
• Identify abnormal cells
• Examine the number and appearance of cells
• Obtain material for specialised testing
• Classify certain blood cancers
• Assess treatment response in some situations

Not every person with blood cancer needs the same bone marrow evaluation. For example, some blood cancers can sometimes be diagnosed without one.

Bone marrow aspiration vs biopsy

Although they are often performed together, these procedures collect different samples.

Bone marrow aspiration collects liquid marrow.

Bone marrow biopsy collects a small solid sample of marrow and bone.

Samples are most often collected from the hip bone.

Local anaesthesia is usually given to numb the area before the procedure. You may feel pressure or discomfort during the procedure, and the aspiration can cause brief, sharp pain or stinging.

If you are worried about pain or anxiety, ask your healthcare team beforehand about the pain-relief or sedation options available.

Before the procedure, tell the team about any medicines and supplements you take and any allergies you have.

Do not stop or change a prescribed medicine unless the clinician responsible for your care tells you to do so.

What happens after a bone marrow test?

After the sample is collected, pressure is applied to the site and a dressing is placed over it. Some soreness or bruising may occur afterwards.

Follow the instructions given by your own treatment center, particularly if you have low platelet counts, take medicines that affect bleeding or have received sedation.

Contact your healthcare team according to their instructions if you develop problems such as:

• Bleeding that does not stop
• Severe pain
• Fever
• Redness or swelling around the procedure site

These are recognised reasons to contact your care team after bone marrow aspiration or biopsy.

What specialised tests may be performed?

A blood or bone marrow sample may undergo several types of laboratory testing.

Immunophenotyping and flow cytometry

The immune system and blood-forming system contain many specialised types of cells. These cells have characteristic proteins, often called antigens or markers, that can help specialists identify them.

Immunophenotyping uses antibodies to identify cells according to these markers. It can help diagnose and monitor several blood cancers.

Cytogenetic and molecular testing

Cytogenetic testing examines chromosomes inside cells. Certain chromosome changes may help with diagnosis, classification, treatment planning or monitoring.

FISH, or fluorescence in situ hybridisation, can look for selected chromosome abnormalities.

Molecular tests can identify particular changes in genes, proteins or other molecules. Their importance depends on the specific cancer. In acute myeloid leukaemia (AML), for example, cytogenetic, FISH and molecular testing may contribute to diagnosis and treatment planning.

This is why your doctor may know the broad diagnosis while some detailed results are still pending.

Are molecular tests checking whether your cancer is inherited?

Not necessarily.

Many tests performed on cancer cells look for somatic changes, which are changes that developed during a person’s lifetime and are present in the cancer. These generally cannot be passed on to children.

This differs from germline genetic testing, which looks for inherited genetic changes.

If genetic testing is discussed, ask:

“Is this test looking at changes in my cancer cells, or is it checking for an inherited genetic change?”

How does the immune system fit into blood cancer care?

The immune system is not simply “strong” or “weak”. It is a complex network of cells, tissues and signalling molecules that helps the body recognise and respond to infections and abnormal cells.

Some cancers can avoid immune recognition or interfere with the body’s immune response. Conventional cancer immunotherapies are established medical treatments that act on specific immune pathways to help the immune system recognise or respond to cancer cells.

How Cancer Healer Center Can Support You

At Cancer Healer Center, Cancer Healer Therapy (CAM) is an individualised, immune-focused supportive approach used alongside the patient’s existing cancer treatment plan.

The CHC team considers the patient’s diagnosis, available test results, treatment history, current health, supportive-care needs and ongoing oncology plan. Cancer Healer Therapy is different from conventional cancer immunotherapy and is not intended to replace, delay or change prescribed cancer treatment.

What happens when all your results are available?

Once enough information is available, your specialist can discuss the diagnosis and appropriate next steps.

Treatment decisions may depend on:

• The exact cancer and subtype
• Chromosome or molecular findings
• Disease characteristics
• Your age and overall health
• Organ function and other medical conditions
• Previous treatments
• Your preferences and treatment goals

Depending on the specific blood cancer, management may include chemotherapy, targeted therapy, immunotherapy, radiotherapy, stem-cell transplantation, other disease-specific treatment or monitoring without immediate treatment.

Not everyone needs the same treatment. Treatment decisions depend on the diagnosis and each person’s clinical assessment.

Questions to ask at your next appointment

Consider asking:

1. What is the exact type and subtype of my blood cancer?
2. Which results are confirmed and which are still pending?
3. Do I need a bone marrow aspiration or biopsy?
4. Have chromosome or molecular tests been requested?
5. Could any pending result affect my treatment?
6. When should I expect the remaining results?
7. How soon do we need to make treatment decisions?
8. Who should I contact if I become unwell?
9. If I am considering Cancer Healer Therapy (CAM), how can it be coordinated with my existing cancer treatment?

When should you seek urgent medical help?

Your individual risk depends on your blood cancer, blood counts and treatment. Follow the emergency instructions provided by your cancer team.

If your team has told you to contact them urgently for fever or possible infection during cancer treatment, follow those instructions promptly.

Seek emergency medical care for severe symptoms such as:

• Severe difficulty breathing
• Severe or uncontrolled bleeding
• Loss of consciousness
• New severe confusion
• Severe chest pain
• Another rapidly worsening medical emergency

Do not replace urgent medical assessment with a routine appointment or supportive-care consultation.

What to do next

If you have recently been diagnosed with blood cancer, review both confirmed and pending test results with your haematologist or haemato-oncologist. Ask which findings may influence your treatment plan and when the remaining results are expected.

If you are also exploring integrative supportive care, you can speak with the Cancer Healer Center team about whether Cancer Healer Therapy (CAM) may have a role within your wider cancer-care plan. The CHC team will consider your diagnosis, current health, treatment history and ongoing care plan before discussing whether the approach may be suitable.

References

1. National Cancer Institute (NCI). How Cancer Is Diagnosed. National Cancer Institute, National Institutes of Health (NIH), U.S. Department of Health and Human Services. Updated 17 January 2023. Accessed 28 August 2026.
2. American Cancer Society. Bone Marrow Biopsy and Aspiration. American Cancer Society. Last revised 26 March 2026. Accessed 28 August 2026. Prepared by the American Cancer Society medical and editorial content team.
3. PDQ® Adult Treatment Editorial Board. PDQ Acute Myeloid Leukemia Treatment — Patient Version. Bethesda, MD: National Cancer Institute, National Institutes of Health. Updated 16 May 2025. Accessed 28 August 2026. PMID: 26389377. NCI states that its PDQ summaries are based on independent reviews of the medical literature and are regularly reviewed and updated.
4. National Cancer Institute (NCI). Biomarker Testing for Cancer Treatment. National Cancer Institute, National Institutes of Health (NIH), U.S. Department of Health and Human Services. Updated 14 December 2021. Accessed 28 August 2026.
5. PDQ® Adult Treatment Editorial Board. PDQ Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment — Patient Version. Bethesda, MD: National Cancer Institute, National Institutes of Health. Updated 17 November 2023. Accessed 28 August 2026. PMID: 26389437.